P Kushalnagar1, Alina Engelman2, G Sadler3. 1. Department of Psychology, Gallaudet University, Washington, D.C, United States. Electronic address: Poorna.kushalnagar@gallaudet.edu. 2. Department of Nursing and Health Sciences, California State University, East Bay, United States. 3. Moore Cancer Center, University of California, San Diego, United States.
Abstract
OBJECTIVE: To assess whether mode of communication and patient centered communication (PCC) with physicians were associated with the likelihood of deaf smokers inquiring about lung cancer screening. METHODS: An accessible health survey including questions about PCC, modes of communication, smoking status and lung cancer screening was administered in American Sign Language (HINTS-ASL) to a nationwide sample of deaf adults from February to August 2017. Of 703 deaf adults who answered the lung screening question, 188 were 55-80 years old. RESULTS: The odds ratio of asking about a lung cancer screening test was higher for people with lung disease or used ASL (directly or through an interpreter) to communicate with their physicians. PCC was not associated with asking about a lung cancer screening test. CONCLUSION: Current or former smokers who are deaf and use ASL are at greater risk for poorer health outcomes if they do not have accessible communication with their physicians. PRACTICE IMPLICATIONS: Optimal language access through interpreters or directly in ASL is critical when discussing smoking cessation or lung cancer screening tests. Counseling and shared decision-making will help improve high-risk deaf patients' understanding and decision-making about lung cancer screening.
OBJECTIVE: To assess whether mode of communication and patient centered communication (PCC) with physicians were associated with the likelihood of deaf smokers inquiring about lung cancer screening. METHODS: An accessible health survey including questions about PCC, modes of communication, smoking status and lung cancer screening was administered in American Sign Language (HINTS-ASL) to a nationwide sample of deaf adults from February to August 2017. Of 703 deaf adults who answered the lung screening question, 188 were 55-80 years old. RESULTS: The odds ratio of asking about a lung cancer screening test was higher for people with lung disease or used ASL (directly or through an interpreter) to communicate with their physicians. PCC was not associated with asking about a lung cancer screening test. CONCLUSION: Current or former smokers who are deaf and use ASL are at greater risk for poorer health outcomes if they do not have accessible communication with their physicians. PRACTICE IMPLICATIONS: Optimal language access through interpreters or directly in ASL is critical when discussing smoking cessation or lung cancer screening tests. Counseling and shared decision-making will help improve high-risk deaf patients' understanding and decision-making about lung cancer screening.
Authors: Steven L Barnett; Kelly A Matthews; Erika J Sutter; Lori A DeWindt; Jacqueline A Pransky; Amanda M O'Hearn; Tamala M David; Robert Q Pollard; Vincent J Samar; Thomas A Pearson Journal: Am J Prev Med Date: 2017-03 Impact factor: 5.043
Authors: Kathryn L Taylor; Charlotte J Hagerman; George Luta; Paula G Bellini; Cassandra Stanton; David B Abrams; Jenna A Kramer; Eric Anderson; Shawn Regis; Andrea McKee; Brady McKee; Ray Niaura; Harry Harper; Michael Ramsaier Journal: Lung Cancer Date: 2017-02-15 Impact factor: 5.705
Authors: Margaret M Byrne; Evelyn P Davila; Wei Zhao; Dorothy Parker; Monica Webb Hooper; Alberto Caban-Martinez; Noella Dietz; Youjie Huang; Antoine Messiah; David J Lee Journal: Cancer Epidemiol Date: 2010-07-23 Impact factor: 2.984
Authors: Kevin Morisod; Mary Malebranche; Joachim Marti; Jacques Spycher; Véronique S Grazioli; Patrick Bodenmann Journal: Eur J Public Health Date: 2022-08-01 Impact factor: 4.424
Authors: Tyler G James; Michael M McKee; Meagan K Sullivan; Glenna Ashton; Stephen J Hardy; Yary Santiago; David G Phillips; JeeWon Cheong Journal: Public Health Rep Date: 2021-06-23 Impact factor: 3.117